Dr. Pasi A. Jänne commented on Bristol-Myers Squibb’s new cancer drug, Opdivo, which is working so well that its clinical trial in lung cancer will be stopped two years ahead of schedule.
Tags: LungCancer, Smoking
Dr. Pasi Janne is leading a study on a new lung cancer treatment that targets tumors in patients with a genetic mutation.
Tags: LungCancer, Genetics
Tags: BasicResearch, Genomics, LungCancer
Tags: BasicResearch, LungCancer
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: